1. The use of adenoviral vectors in gene therapy and vaccine approaches
    Natália Meneses Araújo et al, 2022, Genetics and Molecular Biology CrossRef
  2. RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480
    Chen-Chen Huang et al, 2021, BMC Cancer CrossRef
  3. RGD-p21Ras-scFv expressed prokaryotically on a pilot scale inhibits ras-driven colorectal cancer growth by blocking p21Ras-GTP
    Peng Lin et al, 2024, BMC Cancer CrossRef
  4. Generation and functional analysis of single chain variable fragments (scFvs) targeting the nucleocapsid protein of Porcine epidemic diarrhea virus
    Fengqing Wang et al, 2022, Applied Microbiology and Biotechnology CrossRef
  5. Therapeutic Potential of Intrabodies for Cancer Immunotherapy: Current Status and Future Directions
    Thomas Böldicke, 2022, Antibodies CrossRef
  6. BR2 cell penetrating peptide effectively delivers anti-p21Ras scFv to tumor cells with ganglioside expression for therapy of ras-driven tumor
    Ting Yu et al, 2022, PLOS ONE CrossRef
  7. TLR2 and TLR9 Blockade Using Specific Intrabodies Inhibits Inflammation-Mediated Pancreatic Cancer Cell Growth
    Amrendra K. Ajay et al, 2024, Antibodies CrossRef
  8. The antitumor efficacy of anti-p21Ras scFv mediated by the dual-promoter-regulated recombinant adenovirus KGHV300
    X Y Pan et al, 2017, Gene Therapy CrossRef
  9. Targeting Ras with Macromolecules
    Dehua Pei et al, 2018, Cold Spring Harbor Perspectives in Medicine CrossRef
  10. Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer
    Shuang Bai et al, 2017, International Journal of Molecular Medicine CrossRef
  11. Recombinant Adenovirus KGHV500 and CIK Cells Codeliver Anti-p21-Ras scFv for the Treatment of Gastric Cancer with Wild-Type Ras Overexpression
    Mingjuan Wang et al, 2018, Molecular Therapy - Oncolytics CrossRef
  12. CIK cell-based delivery of recombinant adenovirus KGHV500 carrying the anti-p21Ras scFv gene enhances the anti-tumor effect and safety in lung cancer
    Xin-Rui Lin et al, 2019, Journal of Cancer Research and Clinical Oncology CrossRef